Stay updated on ARRY-382 Combo With Pembrolizumab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the ARRY-382 Combo With Pembrolizumab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ARRY-382 Combo With Pembrolizumab in Solid Tumors Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden message, blocking access to the study record; previously visible study-related content such as contact information, documents, and location details is no longer displayed.
    Difference
    20%
    Check dated 2026-09-19T22:25:25.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.6, updating the site’s version tag from v3.6.5. This reflects a backend/platform update and does not modify the study data or user-facing content.
    Difference
    0.0%
    Check dated 2026-08-29T20:42:34.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.4 to v3.6.5, indicating a newer build of the Study Details page. This behind-the-scenes update does not modify the displayed content or study results.
    Difference
    0.0%
    Check dated 2026-08-08T17:07:46.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.4, replacing Revision: v3.6.3. This indicates a new site release without changes to study content.
    Difference
    0.0%
    Check dated 2026-07-25T10:23:52.000Z thumbnail image
  7. Check
    93 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.2 to v3.6.3, indicating a small update to the page.
    Difference
    0.0%
    Check dated 2026-07-03T23:15:49.000Z thumbnail image
  8. Check
    100 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.0 to v3.6.2, indicating a newer page revision. This update does not modify the study details or other visible content.
    Difference
    0.0%
    Check dated 2026-06-26T23:15:44.000Z thumbnail image

Stay in the know with updates to ARRY-382 Combo With Pembrolizumab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ARRY-382 Combo With Pembrolizumab in Solid Tumors Clinical Trial page.